Carbohydrate-binding
proteins (lectins) play vital roles in cell
recognition and signaling, including pathogen binding and innate immunity.
Thus, targeting lectins, especially those on the surface of immune
cells, could advance immunology and drug discovery. Lectins are typically
oligomeric; therefore, many of the most potent ligands are multivalent.
An effective strategy for lectin targeting is to display multiple
copies of a single glycan epitope on a polymer backbone; however,
a drawback to such multivalent ligands is they cannot distinguish
between lectins that share monosaccharide binding selectivity (e.g.,
mannose-binding lectins) as they often lack molecular precision. Here,
we describe the development of an iterative exponential growth (IEG)
synthetic strategy that enables facile access to synthetic glycomacromolecules
with precisely defined and tunable sizes up to 22.5 kDa, compositions,
topologies, and absolute configurations. Twelve discrete mannosylated
“glyco-IEGmers” are synthesized and screened for binding
to a panel of mannoside-binding immune lectins (DC-SIGN, DC-SIGNR,
MBL, SP-D, langerin, dectin-2, mincle, and DEC-205). In many cases,
the glyco-IEGmers had distinct length, stereochemistry, and topology-dependent
lectin-binding preferences. To understand these differences, we used
molecular dynamics and density functional theory simulations of octameric
glyco-IEGmers, which revealed dramatic effects of glyco-IEGmer stereochemistry
and topology on solution structure and reveal an interplay between
conformational diversity and chiral recognition in selective lectin
binding. Ligand function also could be controlled by chemical substitution:
by tuning the side chains of glyco-IEGmers that bind DC-SIGN, we could
alter their cellular trafficking through alteration of their aggregation
state. These results highlight the power of precision synthetic oligomer/polymer
synthesis for selective biological targeting, motivating the development
of next-generation glycomacromolecules tailored for specific immunological
or other therapeutic applications.